Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.
about
In Vitro Antifungal Susceptibility of Yeast and Mold Phases of Isolates of Dimorphic Fungal Pathogen Emergomyces africanus (Formerly Emmonsia sp.) from HIV-Infected South African Patients.Antifungal therapeutics for dimorphic fungal pathogens.Blastomycotic osteomyelitis associated with severe lameness in a horse.Antifungal susceptibility of emerging dimorphic pathogens in the family Ajellomycetaceae.
P2860
Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Susceptibilities of clinical a ...... itraconazole, and fluconazole.
@ast
Susceptibilities of clinical a ...... itraconazole, and fluconazole.
@en
type
label
Susceptibilities of clinical a ...... itraconazole, and fluconazole.
@ast
Susceptibilities of clinical a ...... itraconazole, and fluconazole.
@en
prefLabel
Susceptibilities of clinical a ...... itraconazole, and fluconazole.
@ast
Susceptibilities of clinical a ...... itraconazole, and fluconazole.
@en
P2093
P2860
P1476
Susceptibilities of clinical a ...... itraconazole, and fluconazole.
@en
P2093
D C Sullivan
M G Rinaldi
P D Rogers
S W Chapman
P2860
P304
P407
P577
1998-04-01T00:00:00Z